Stratos Wealth Partners LTD. increased its position in BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 7.9% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 7,037 shares of the company’s stock after acquiring an additional 517 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in BlackRock Health Sciences Trust were worth $272,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in BME. Invesco Ltd. raised its holdings in BlackRock Health Sciences Trust by 8.9% in the fourth quarter. Invesco Ltd. now owns 223,316 shares of the company’s stock worth $8,470,000 after purchasing an additional 18,213 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in BlackRock Health Sciences Trust by 5.3% in the fourth quarter. Ameriprise Financial Inc. now owns 172,829 shares of the company’s stock worth $6,554,000 after purchasing an additional 8,622 shares in the last quarter. Cornerstone Advisory LLC grew its stake in shares of BlackRock Health Sciences Trust by 13.3% in the fourth quarter. Cornerstone Advisory LLC now owns 152,301 shares of the company’s stock worth $6,119,000 after acquiring an additional 17,847 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in shares of BlackRock Health Sciences Trust in the fourth quarter worth $3,250,000. Finally, Cambridge Investment Research Advisors Inc. grew its stake in shares of BlackRock Health Sciences Trust by 14.1% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 50,654 shares of the company’s stock worth $1,957,000 after acquiring an additional 6,257 shares during the last quarter.
BlackRock Health Sciences Trust Price Performance
NYSE BME opened at $35.80 on Wednesday. BlackRock Health Sciences Trust has a 12 month low of $34.18 and a 12 month high of $42.64. The stock’s fifty day moving average price is $36.14 and its 200-day moving average price is $37.78.
BlackRock Health Sciences Trust Dividend Announcement
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
See Also
- Five stocks we like better than BlackRock Health Sciences Trust
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth
- Investing In Preferred Stock vs. Common Stock
- Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook
- Are Penny Stocks a Good Fit for Your Portfolio?
- Fastenal Surges After Earnings Beat, Tariff Risks Loom
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.